Interleukin-1 gene cluster polymorphisms in cerebral infarction

被引:21
作者
Um, JY
Moon, KS
Lee, KM
Kim, HM
机构
[1] Kyung Hee Univ, Coll Oriental Med, Dept Pharmacol, Seoul 130701, South Korea
[2] Chonbuk Natl Univ, Coll Nat Sci, Div Biol Sci, Jeonju 561756, Jeonbuk, South Korea
关键词
cerebral infarction; interleukin-1; polymorphism;
D O I
10.1016/S1043-4666(03)00183-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-1 (IL-1) has pleiotropic actions in the central nervous system. During the past decade, a growing corpus of evidence has indicated an important role of this cytokine in the development of brain damage following cerebral ischaemia. The expression of IL-1 in the brain is dramatically increased during the early and chronic stage of infarction. The IL-1 gene cluster on chromosome 2ql4 contains three related genes (IL-1alpha, IL-1beta, and IL-1 receptor antagonist, IL-1ra) located within a 430-kb region. Polymorphisms in the genes encoding IL-1alpha, IL-1beta, and IL-1ra have been associated with several inflammatory diseases. Therefore we hypothesized that these cytokines might be good candidates for cerebral infarction (CI). We ascertained these genotypes in 363 CI patients and 640 controls matched for age and gender. A significant increase was found for the IL-1alpha (-889) allele 2 carriers in CI patients compared with controls (chi(2) = 5.633, P = 0.018, odds ratio (OR)=1.5). Furthermore, the IL-1 a (-889) allele 2 carriers increased the relative risk for CI in the subjects without the IL-1ra allele 2 (chi(2) = 7.989, P = 0.005, OR= 1.7). There was no significant association between IL-1beta (+3953) polymorphism and CI. These results suggest that IL-1alpha-889 and IL-1ra polymorphisms are effective in the development of CI in Koreans. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:41 / 46
页数:6
相关论文
共 48 条
  • [1] Cortical cell death induced by IL-1 is mediated via actions in the hypothalamus of the rat
    Allan, SM
    Parker, LC
    Collins, B
    Davies, R
    Luheshi, GN
    Rothwell, NJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) : 5580 - 5585
  • [2] Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies
    Andreotti, F
    Porto, I
    Crea, F
    Maseri, A
    [J]. HEART, 2002, 87 (02) : 107 - 112
  • [3] ATTENUATION OF STROKE SIZE IN RATS USING AN ADENOVIRAL VECTOR TO INDUCE OVEREXPRESSION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN BRAIN
    BETZ, AL
    YANG, GY
    DAVIDSON, BL
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1995, 15 (04) : 547 - 551
  • [4] BIOQUE G, 1995, CLIN EXP IMMUNOL, V102, P379
  • [5] Clay FE, 1996, HUM GENET, V97, P723
  • [6] DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303
  • [7] Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis
    Dewberry, R
    Holden, H
    Crossman, D
    Francis, S
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (11) : 2394 - 2400
  • [8] Di Giovine F. S., 1992, Human Molecular Genetics, V1, P450
  • [9] Biologic basis for interleukin-1 in disease
    Dinarello, CA
    [J]. BLOOD, 1996, 87 (06) : 2095 - 2147
  • [10] Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1α
    Dominici, R
    Cattaneo, M
    Malferrari, G
    Archi, D
    Mariani, C
    Grimaldi, LME
    Biunno, I
    [J]. IMMUNOGENETICS, 2002, 54 (02) : 82 - 86